Back to Search
MARELLE GIULIANO, MD
MD
Anesthesiology Physician
NPI: 1306541917Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
11022792A(IN)
Research & Publications (20)
Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptions.
PMID 19074663·J Med Microbiol·2009
2-rct
Effects of low concentrations of benzene on human lung cells in vitro.
PMID 19446245·Toxicol Lett·2009
8-other
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis.
PMID 19474115·Ann Oncol·2009
4-observational
An alpha/beta-peptide helix bundle with a pure beta3-amino acid core and a distinctive quaternary structure.
PMID 19580264·J Am Chem Soc·2009
8-other
Inequalities in health: access to treatment for HIV/AIDS.
PMID 18209264·Ann Ist Super Sanita·2007
6-review
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
PMID 17146372·J Acquir Immune Defic Syndr·2007
3-trial
Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway.
PMID 16596265·Int J Mol Med·2006
8-other
Expression of Sulfolobus solfataricus alpha-glucosidase in Lactococcus lactis.
PMID 15168096·Appl Microbiol Biotechnol·2004
8-other
Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL.
PMID 15010857·Int J Mol Med·2004
8-other
Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs.
PMID 14677428·Ital J Biochem·2003
6-review
Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelioma cells.
PMID 10812006·Int J Mol Med·2000
7-preclinical
Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology.
PMID 19621432·Pediatr Blood Cancer·2009
3-trial
The importance of testing genotypic resistance in proviral DNA of patients fully responding to highly active antiretroviral therapy.
PMID 19465827·J Acquir Immune Defic Syndr·2009
8-other
Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
PMID 19114976·Med Sci Monit·2009
8-other
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
PMID 19160414·J Cell Physiol·2009
8-other
High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases.
PMID 19298651·J Exp Clin Cancer Res·2009
8-other
Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients.
PMID 19458492·Cancer Biol Ther·2009
8-other
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
PMID 19459989·HIV Med·2009
4-observational
Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries.
PMID 19657392·PLoS One·2009
8-other
Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.
PMID 19552594·AIDS Res Hum Retroviruses·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1633 N CAPITOL AVE STE 640
INDIANAPOLIS, IN 46202 - Phone
- (317) 962-8881
Quick Facts
- NPI
- 1306541917
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile